PMID- 24231806 OWN - NLM STAT- MEDLINE DCOM- 20140108 LR - 20240503 IS - 1095-9203 (Electronic) IS - 0036-8075 (Print) IS - 0036-8075 (Linking) VI - 342 IP - 6165 DP - 2013 Dec 20 TI - mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. PG - 1524-8 LID - 10.1126/science.1244360 [doi] AB - Mitochondrial dysfunction contributes to numerous health problems, including neurological and muscular degeneration, cardiomyopathies, cancer, diabetes, and pathologies of aging. Severe mitochondrial defects can result in childhood disorders such as Leigh syndrome, for which there are no effective therapies. We found that rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, robustly enhances survival and attenuates disease progression in a mouse model of Leigh syndrome. Administration of rapamycin to these mice, which are deficient in the mitochondrial respiratory chain subunit Ndufs4 [NADH dehydrogenase (ubiquinone) Fe-S protein 4], delays onset of neurological symptoms, reduces neuroinflammation, and prevents brain lesions. Although the precise mechanism of rescue remains to be determined, rapamycin induces a metabolic shift toward amino acid catabolism and away from glycolysis, alleviating the buildup of glycolytic intermediates. This therapeutic strategy may prove relevant for a broad range of mitochondrial diseases. FAU - Johnson, Simon C AU - Johnson SC AD - Department of Pathology, University of Washington, Seattle, WA 98195, USA. FAU - Yanos, Melana E AU - Yanos ME FAU - Kayser, Ernst-Bernhard AU - Kayser EB FAU - Quintana, Albert AU - Quintana A FAU - Sangesland, Maya AU - Sangesland M FAU - Castanza, Anthony AU - Castanza A FAU - Uhde, Lauren AU - Uhde L FAU - Hui, Jessica AU - Hui J FAU - Wall, Valerie Z AU - Wall VZ FAU - Gagnidze, Arni AU - Gagnidze A FAU - Oh, Kelly AU - Oh K FAU - Wasko, Brian M AU - Wasko BM FAU - Ramos, Fresnida J AU - Ramos FJ FAU - Palmiter, Richard D AU - Palmiter RD FAU - Rabinovitch, Peter S AU - Rabinovitch PS FAU - Morgan, Philip G AU - Morgan PG FAU - Sedensky, Margaret M AU - Sedensky MM FAU - Kaeberlein, Matt AU - Kaeberlein M LA - eng GR - T32AG000057/AG/NIA NIH HHS/United States GR - P01 AG001751/AG/NIA NIH HHS/United States GR - T32ES007032/ES/NIEHS NIH HHS/United States GR - T32 AG000057/AG/NIA NIH HHS/United States GR - R01 AG039390/AG/NIA NIH HHS/United States GR - T32 ES007032/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20131114 PL - United States TA - Science JT - Science (New York, N.Y.) JID - 0404511 RN - 0 (Multiprotein Complexes) RN - 0 (Ndufs4 protein, mouse) RN - 0 (Neuroprotective Agents) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 7.1.1.2 (Electron Transport Complex I) RN - W36ZG6FT64 (Sirolimus) SB - IM CIN - Nat Rev Neurol. 2014 Jan;10(1):2. PMID: 24296657 CIN - Science. 2013 Dec 20;342(6165):1453-4. PMID: 24357304 MH - Animals MH - Brain/drug effects/enzymology/pathology MH - Disease Models, Animal MH - Electron Transport Complex I/genetics/metabolism MH - Glycolysis/drug effects MH - Leigh Disease/*drug therapy/genetics/pathology MH - Mechanistic Target of Rapamycin Complex 1 MH - Mice MH - Mice, Knockout MH - Mice, Mutant Strains MH - Mitochondria/drug effects/enzymology MH - Mitochondrial Diseases/*drug therapy/genetics/pathology MH - *Molecular Targeted Therapy MH - Multiprotein Complexes/*antagonists & inhibitors MH - Neuroprotective Agents/*therapeutic use MH - Sirolimus/*therapeutic use MH - TOR Serine-Threonine Kinases/*antagonists & inhibitors PMC - PMC4055856 MID - NIHMS584331 EDAT- 2013/11/16 06:00 MHDA- 2014/01/09 06:00 PMCR- 2014/06/20 CRDT- 2013/11/16 06:00 PHST- 2013/11/16 06:00 [entrez] PHST- 2013/11/16 06:00 [pubmed] PHST- 2014/01/09 06:00 [medline] PHST- 2014/06/20 00:00 [pmc-release] AID - science.1244360 [pii] AID - 10.1126/science.1244360 [doi] PST - ppublish SO - Science. 2013 Dec 20;342(6165):1524-8. doi: 10.1126/science.1244360. Epub 2013 Nov 14.